A 12-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy and Safety of HP-5000 Topical System (Patch) in Subjects With Osteoarthritis Pain of the Knee
Latest Information Update: 24 Jul 2023
At a glance
- Drugs Diclofenac (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Registrational; Therapeutic Use
- Sponsors Noven Pharmaceuticals Inc
- 19 Aug 2022 Status changed from recruiting to completed.
- 19 Aug 2022 Status changed from recruiting to completed.
- 30 Nov 2020 New trial record